Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06717373 · ClinicalTrials.gov registry record · NA
Point-of-Care Echocardiography in Patients with Known or Suspected Aortic Stenosis
A NA study of Patients with an Indication for an Echocardiographic Examination with Suspicion of Valcular Heart Disease, sponsored by Caption Health.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06717373: Recruiting NA study of Patients with an Indication for an Echocardiographic Examination with Suspicion of Valcular Heart Disease, sponsored by Caption Health.
NCT06717373 is a NA study of Patients with an Indication for an Echocardiographic Examination with Suspicion of Valcular Heart Disease that is actively recruiting participants, run by Caption Health. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06717373, a NA study of Patients with an Indication for an Echocardiographic Examination with Suspicion of Valcular Heart Disease, is actively recruiting participants, sponsored by Caption Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective clinical trial intended to capture echocardiographic images in patients clinically indicated for an echocardiographic examination using an additional Point of Care Ultrasound device . The images collected will be used to test and possibly validation an AI base Aortic Valve Stenosis algorithm
Primary Outcome
The primary endpoints are the sensitivity and specificity of the Caption AutoAS algorithm for the absence (none/mild AS) or presence (moderate/severe AS) of AS relative to that indicated in the echocardiographic examination.
Conditions Studied
Interventions
- DEVICE AutoAS
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-02-07 |
| Est. Completion | 2025-04-01 |
| Phase | NA |
What NCT06717373 shows while recruiting
NCT06717373 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Patients with an Indication for an Echocardiographic Examination with Suspicion of Valcular Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which AutoAS is the first listed.
NCT06717373 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06717373 about?
NCT06717373 is a clinical study titled "Point-of-Care Echocardiography in Patients with Known or Suspected Aortic Stenosis". This is a prospective clinical trial intended to capture echocardiographic images in patients clinically indicated for an echocardiographic examination using an additional Point of Care Ultrasound device . The images collected will be used to test and possibly validation an AI base Aortic Valve Sten...
What is the current status of trial NCT06717373?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-02-07. Estimated completion is 2025-04-01.
What conditions does trial NCT06717373 study?
This clinical trial studies the following conditions: Patients with an Indication for an Echocardiographic Examination with Suspicion of Valcular Heart Disease.
What interventions are being tested in trial NCT06717373?
The interventions under investigation include: AutoAS (DEVICE).
Who is sponsoring clinical trial NCT06717373?
This trial is sponsored by Caption Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06717373 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06717373's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI